UCP2 Mutations and Their Role in Congenital Hyperinsulinism
Author Information
Author(s): González-Barroso M. Mar, Giurgea Irina, Bouillaud Fredéric, Anedda Andrea, Bellanné-Chantelot Christine, Hubert Laurence, de Keyzer Yves, de Lonlay Pascale, Ricquier Daniel
Primary Institution: Université Paris Descartes Site Necker-enfants Malades, CNRS UPR 9078 BIOTRAM, Paris, France
Hypothesis
Is UCP2 involved in the regulation of insulin secretion in congenital hyperinsulinism?
Conclusion
The study found that mutations in the UCP2 gene are associated with congenital hyperinsulinism and affect insulin secretion.
Supporting Evidence
- Two unrelated children with congenital hyperinsulinism had heterozygous UCP2 variants.
- Functional assays showed impaired activity of UCP2 mutants.
- The study highlights a role for mitochondria in hormone secretion.
Takeaway
Some kids with a condition that makes them produce too much insulin have changes in a gene called UCP2, which helps control how insulin is released.
Methodology
The study involved genetic analysis of ten children with congenital hyperinsulinism and functional assays in yeast and insulin-secreting cells.
Limitations
The study only included a small sample size of ten children, which may limit the generalizability of the findings.
Participant Demographics
The participants were ten children with congenital hyperinsulinism, including two girls with specific UCP2 mutations.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website